Physician profile
Sally Jo
NPI 1467012666
$53,126.62
in general payments reported to CMS, 2019-2025
12 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $6,738 · 2021: $1,214 · 2022: $220 · 2023: $569 · 2024: $31K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $40K · Travel and Lodging: $1,719 · Consulting Fee: $1,500 · Food and Beverage: $1,151 · Education: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $40,000.00 |
| Travel and Lodging | $1,719.12 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,150.51 |
| Education | $312.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20,000.00 | 2024-2025 | |
| Arthrex, INC. | $20,000.00 | 2024 | |
| Elite Orthopedics, LLC | $6,422.19 | 2020 | |
| Encore Medical, LP | $3,219.12 | 2024-2025 | Djo Surgical |
| Medical Device Business Services, INC. | $1,462.25 | 2019-2024 | Inhance |
| Stryker Corporation | $1,102.90 | 2021-2024 | Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $419.87 | 2023-2024 | Attune, Hammerlock, Na |
| Exactech, INC. | $192.44 | 2025 | |
| Davol INC. | $163.84 | 2024 | Arista Ah Flexitip |
| Baxter Healthcare | $115.38 | 2025 | Floseal |
| Acell, INC. | $16.12 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Jo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.